Younger age at HAART initiation is associated with more rapid growth reconstitution

AIDS

Volumn 25, Issue 3, 2011, Pages 345-355

  McGrath, Christine J ^a   Chung, Michael H ^a   Richardson, Barbra A ^a,b   Benki Nugent, Sarah ^a   Warui, Danson ^c   John Stewart, Grace C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Internal Medicine and Critical care Department   (Kenya)

Author keywords

growth; HAART; HIV; nutritional supplementation; pediatrics; sub Saharan Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

ADJUSTMENT; AGE; ARTICLE; BODY GROWTH; BODY HEIGHT; BODY WEIGHT; CATCH UP GROWTH; CHILD; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXPERIENCE; FEMALE; GROWTH ACCELERATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; KENYA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PEER COUNSELING; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SCHOOL CHILD; SCORING SYSTEM; SURVIVAL RATE; VITAMIN SUPPLEMENTATION; WEIGHT GAIN; WORLD HEALTH ORGANIZATION;

AGE FACTORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KAPLAN-MEIER ESTIMATE; KENYA; MALE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 79551590926     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834171db     Document Type: Article

References (45)

1. UNAIDS. Paediatric HIV infection and AIDS: UNAIDS point of view. Edited by UNAIDS. Geneva, Switzerland: UNAIDS; September 2002:8.
2. WHO. Early detection of HIV infection in infants and children. Geneva, Switzerland: WHO; May 2007.
3. Arpadi SM. Growth failure in children with HIV infection. J Acquir Immune Defic Syndr 2000; 25 (Suppl 1):S37-S42.
4. McKinney RE Jr, Robertson JW. Effect of human immunodeficiency virus infection on the growth of young children. Duke Pediatric AIDS Clinical Trials Unit. J Pediatr 1993; 123:579-582.
5. Miller TL, Evans SJ, Orav EJ, Morris V, McIntosh K, Winter HS. Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr 1993; 57:588-592.
6. Nachman SA, Lindsey JC, Moye J, Stanley KE, Johnson GM, Krogstad PA, Wiznia AA. Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J 2005; 24:352-357.
7. Mahlungulu S, Grobler LA, Visser ME, Volmink J. Nutritional interventions for reducing morbidity and mortality in people with HIV. Cochrane Database Syst Rev 2007; CD004536.
8. Anabwani G, Navario P. Nutrition and HIV/AIDS in sub- Saharan Africa: an overview. Nutrition 2005; 21:96-99.
9. Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics 2002; 109:E25.
10. Kekitiinwa A, Lee KJ, Walker AS, Maganda A, Doerholt K, Kitaka SB, et al. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr 2008; 49:384-392.
11. Wamalwa DC, Farquhar C, Obimbo EM, Selig S, Mbori-Ngacha DA, Richardson BA, et al. Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. J Acquir Immune Defic Syndr 2007; 45:311-317.
12. De Beaudrap P, Rouet F, Fassinou P, Kouakoussui A, Mercier S, Ecochard R, Msellati P. CD4 cell response before and after HAART initiation according to viral load and growth indicators in HIV-1-infected children in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr 2008; 49:70-76.
13. Kabue MM, Kekitiinwa A, Maganda A, Risser JM, Chan W, Kline MW. Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient Care STDS 2008; 22:245-251.
14. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary healthcare facilities in Zambia. JAMA 2007; 298:1888-1899.
15. Chantry CJ, Byrd RS, Englund JA, Baker CJ, McKinney RE Jr. Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection. Pediatr Infect Dis J 2003; 22:1033-1039.
16. Lindsey JC, Hughes MD, McKinney RE, Cowles MK, Englund JA, Baker CJ, et al. Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected children. J Infect Dis 2000; 182:1385-1393.
17. Denny T, Yogev R, Gelman R, Skuza C, Oleske J, Chadwick E, et al. Lymphocyte subsets in healthy children during the first 5 years of life. JAMA 1992; 267:1484-1488.
18. Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group.N Engl J Med 1997; 336:1337-1342.
19. Englund JA, Baker CJ, Raskino C, McKinney RE, Petrie B, Fowler MG, et al. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med 1997; 336:1704-1712.
20. USAID. Food aid programs and the President's emergency plan for AIDS relief: HIV and food security conceptual framework. Edited by USAID Bureau for Democracy CHA: USAID; September 2007.
21. Chung MH, Drake AL, Richardson BA, Reddy A, Thiga J, Sakr SR, et al. Impact of prior HAART use on clinical outcomes in a large Kenyan HIV treatment program. Curr HIV Res 2009; 7:441-446.
22. WHO. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. In Recommendations for a public health approach. Geneva, Switzerland: WHO Press; 2006. pp. 152.
23. de Onis M, Garza C, Victora CG, Onyango AW, Frongillo EA, Martines J. The WHO Multicentre Growth Reference Study: planning, study design, and methodology. Food Nutr Bull 2004; 25:S15-S26.
24. Miller TL, Agostoni C, Duggan C, Guarino A, Manary M, Velasco CA. Gastrointestinal and nutritional complications of human immunodeficiency virus infection. J Pediatr Gastroenterol Nutr 2008; 47:247-253.
25. Canani RB, Spagnuolo MI, Cirillo P, Guarino A. Ritonavir combination therapy restores intestinal function in children with advanced HIV disease. J Acquir Immune Defic Syndr 1999; 21:307-312.
26. Group TIPIHS. Intestinal malabsorption of HIV-infected children: relationship to diarrhoea, failure to thrive, enteric micro-organisms and immune impairment. AIDS 1993; 7:1435-1440.
27. Quesnel A, Moja P, Blanche S, Griscelli C, Genin C. Early impairment of gut mucosal immunity in HIV-1-infected children. Clin Exp Immunol 1994; 97:380-385.
28. Pernet P, Vittecoq D, Kodjo A, Randrianarisolo MH, Dumitrescu L, Blondon H, et al. Intestinal absorption and permeability in human immunodeficiency virus-infected patients. Scand J Gastroenterol 1999; 34:29-34.
29. Campbell DI, Elia M, Lunn PG. Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation. J Nutr 2003; 133:1332-1338.
30. Gafni RI, Baron J. Catch-up growth: possible mechanisms. Pediatr Nephrol 2000; 14:616-619.
31. Kay's SK, Hindmarsh PC. Catch-up growth: an overview. Pediatr Endocrinol Rev 2006; 3:365-378.
32. Boersma B, Houwen RH, Blum WF, van Doorn J, Wit JM. Catchup growth and endocrine changes in childhood celiac disease. Endocrine changes during catch-up growth. Horm Res 2002; 58 (Suppl 1):57-65.
33. Walters TD, Griffiths AM. Mechanisms of growth impairment in pediatric Crohn's disease. Nat Rev Gastroenterol Hepatol 2009; 6:513-523.
34. Wit JM, Boersma B. Catch-up growth: definition, mechanisms, andmodels. J Pediatr EndocrinolMetab 2002; 15 (Suppl 5):1229-1241.
35. Steiner F, Kind C, Aebi C, Wyler-Lazarevitch CA, Cheseaux JJ, Rudin C, et al. Growth in human immunodeficiency virus type 1-infected children treated with protease inhibitors. Eur J Pediatr 2001; 160:611-616.
36. Arpadi SM, Horlick M, Thornton J, Cuff PA, Wang J, Kotler DP. Bone mineral content is lower in prepubertal HIV-infected children. J Acquir Immune Defic Syndr 2002; 29:450-454.
37. Arpadi SM, McMahon D, Abrams EJ, Bamji M, Purswani M, Engelson ES, et al. Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics 2009; 123:e121-126.
38. O'Brien KO, Razavi M, Henderson RA, Caballero B, Ellis KJ. Bone mineral content in girls perinatally infected with HIV.Am J Clin Nutr 2001; 73:821-826.
39. Rosso R, Vignolo M, Parodi A, Di Biagio A, Sormani MP, Bassetti M, et al. Bone quality in perinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy. AIDS Res Hum Retroviruses 2005; 21:927-932.
40. Jacobson DL, Spiegelman D, Duggan C, Weinberg GA, Bechard L, Furuta L, et al. Predictors of bone mineral density in human immunodeficiency virus-1 infected children. J Pediatr Gastroenterol Nutr 2005; 41:339-346.
41. Amadi B, Mwiya M, Chomba E, Thomson M, Chintu C, Kelly P, Walker-Smith J. Improved nutritional recovery on an elemental diet in Zambian children with persistent diarrhoea and malnutrition. J Trop Pediatr 2005; 51:5-10.
42. Hsu J, Pencharz PB, Macallan D, Tomkins A. Macronutrients an HIV/AIDS: a review of current evidence. Geneva, Switzerland: WHO; 2005. pp. 41.
43. Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ 2000; 320:967-971.
44. Dulloo AG. Thrifty energy metabolism in catch-up growth trajectories to insulin and leptin resistance. Best Pract Res Clin Endocrinol Metab 2008; 22:155-171.
45. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al. Early antiretroviral therapy and mortality among HIVinfected infants. N Engl J Med 2008; 359:2233-2244.